SCHEMBL29630909

SCHEMBL29630909

CCCCOC(=O)C1CNC(=O)C1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.43
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SLC5A1 P13866 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
ATM Q13315 1/20 0.37
ACACB O00763 1/20 0.37
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7542860 0.94 NAAA (0.50) NAAAALDH1A1SLC5A1TSHR
SCHEMBL7542550 0.94 NAAA (0.50) NAAAALDH1A1SLC5A1TSHR
SCHEMBL1874367 0.78 ALDH1A1 (0.45) NAAAPDE4DALDH1A1ATMTSHR
Dodecanol SCHEMBL28693387 0.77 SLC5A1 (0.41) NAAAPDE4APDE4BPDE4CPDE4D
SCHEMBL25299469 0.76 ALDH1A1 (0.47) NAAAALDH1A1ATMTSHRTDP1
Decane SCHEMBL8084226 0.76 SLC5A1 (0.46) NAAAALDH1A1SLC5A1L3MBTL1
Hexadecane SCHEMBL8144910 0.76 SLC5A1 (0.46) NAAAALDH1A1SLC5A1L3MBTL1
SCHEMBL11037027 0.76 ALDH1A1 (0.42) NAAAALDH1A1ATMTSHRTDP1
Hydrochloric Acid SCHEMBL17459536 0.75 ALDH1A1 (0.45) NAAAALDH1A1ATMTSHR
SCHEMBL22279768 0.74 BRD4 (0.46) PDE4APDE4BPDE4CPDE4DACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251623-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 EP disclosed
WO-2022112140-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed